secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0000950170-25-083044
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology shareholders elect all four director nominees and ratify auditor
--------------------------------------------------------------------------------

- All four Class I directors elected: Steven D. Harr (147.9M for), Robert L. Rosiello (158.2M for), Michelle Seitz (147.9M for), Patrick Y. Yang (143.7M for).
- Ratification of Ernst & Young as independent auditor for FY2025: 180.2M for, 55.8K against, 69.6K abstain.
- Broker non-votes of 20.9M shares on director election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000095017025083044/0000950170-25-083044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000095017025083044/sana-20250605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-083044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer